4-(2-Chloroacetamido)benzoic acid

Catalog No.: 
ACRHYI163
CAS No.: 
4596-39-8
Molecular Formula: 
C9H8ClNO3
Molecular Weight: 
213.62
4-(2-Chloroacetamido)benzoic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g95%$77.00In stockIn stock
25g95%$256.00In stockIn stock
100g95%$879.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(2-Chloroacetamido)benzoic acid
IUPAC Name4-(2-chloroacetamido)benzoic acid
MDL No.MFCD00239393
Molecular FormulaC9H8ClNO3
Molecular Weight213.62
SMILESO=C(O)C1=CC=C(NC(CCl)=O)C=C1
InChI KeyFNXAWVZXABMYRM-UHFFFAOYSA-N
SynonymAKOS B029036;AKOS BBS-00003998;TIMTEC-BB SBB003412;4-[(CHLOROACETYL)AMINO]BENZOIC ACID;4-(2-chloroethanoylamino)benzoic acid;4-(2-CHLOROACETAMIDO)BENZOIC ACID;BUTTPARK 80\07-82;LABOTEST-BB LT00452441
CAS No.4596-39-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACRHYI163 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNFPB351 route compound structure diagram
    ACNFPB351138-84-1In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRHYI163 route product structure diagram
    ACRHYI1634596-39-8In Stock
Inquiry

2. ACRHYI163 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNFPB351 route compound structure diagram
    ACNFPB351138-84-1In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRHYI163 route product structure diagram
    ACRHYI1634596-39-8In Stock
Inquiry

3. ACRHYI163 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRHYI163 route product structure diagram
    ACRHYI1634596-39-8In Stock
Inquiry

Comments (0)